Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2025 · 10-Q
Revenue$336.17M$336.17M+8.0% vs Q1 2024 Net Income$38.37M$38.37M−6.5% vs Q1 2024 EPS Diluted$0.74$0.74−7.5% vs Q1 2024 Gross Profit$174,924,000+4.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow-$27,421,000N/M Free Cash Flowderived-$33,077,000N/M Margins · derivedGross margin52.0%−1.7 pt vs Q1 2024
Operating margin11.8%−5.4 pt vs Q1 2024
Net margin11.4%−1.8 pt vs Q1 2024
ended Jun 29, 2024 · filed Aug 8, 2024 · 40 d after period end